تعاون استراتيجي بين إيفلو بايوساينسز و جميل للرعاية الصحية

Reuters reports that Evelo Biosciences and Jameel Health have entered a strategic collaboration to develop and commercialize Evelo’s novel therapy EDP1815 for inflammatory diseases and COVID-19 in select developing markets serving 1.7 billion people.  

Read the full article in its original location here.